ATIM-25. IMMUNOLOGICAL ACTIVATION IN RESPONDING PATIENTS WITH RECURRENT HGG AFTER TREATMENT WITH TOCA 511 & TOCA FC: RESULTS FROM A PHASE 1 TRIALDerek Ostertag,William Accomando,Daniel Hogan,Oscar Diago,Dawn Gammon,Ali Haghighi,Leah Mitchell,Maria Rodriguez-Aquirre,Timothy F. Cloughesy,Steven N. Kalkanis,Tom Mikkelsen,Joseph Landolfi,Clark Chen,Michael A. Vogelbaum,Harry E. Gruber,Asha Das,Douglas J. JollyNeuro-oncology(2017)引用 0|浏览23暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要